Chemokine receptor CCR5: polymorphism at protein level

被引:13
作者
Suzuki, S
Miyagi, T
Chuang, LF
Yau, PM
Doi, RH
Chuang, RY [1 ]
机构
[1] Univ Calif Davis, Dept Med Pharmacol & Toxicol, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA
[3] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA
关键词
chemokine; chemokine receptor CCR5; CCR5; polymorphism; morphine sulfate;
D O I
10.1016/S0006-291X(02)00908-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polymorphisms in chemokine receptor CCR5 genes have been implicated in HIV disease progression, resistance, or non-progressive infection. Multiple CCR5 transcripts and mRNA diversity have also been identified. This study presents evidence to show that two distinct forms of CCR5 protein, 62 and 42kDa, are present in human lymphocytic cells and monkey peripheral blood mononuclear cells, The ratio of these two forms of CCR5 changes with cell growth. The 62 kDa CCR5 predominates if the electrophoresis sample buffer does not contain reducing agent. However, the 62 and the 42kDa CCR5 are not interconvertible. Morphine sulfate induces the formation and expression of both forms of CCR5 whereas RANTES, MIP-1alpha or MIP-1beta inhibits them. Localization studies indicate that the 62 kDa CCR5 resides mainly on the cell membrane and the 42 kDa CCR5 is present solely in the cytoplasm of the cells. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 26 条
[1]   Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity [J].
Blanpain, C ;
Lee, B ;
Vakili, J ;
Doranz, BJ ;
Govaerts, C ;
Migeotte, I ;
Sharron, M ;
Dupriez, V ;
Vassart, G ;
Doms, RW ;
Parmentier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :18902-18908
[2]   Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry [J].
Chen, ZW ;
Zhou, P ;
Ho, DD ;
Landau, NR ;
Marx, PA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2705-2714
[3]   Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate [J].
Chuang, LF ;
Killam, KF ;
Chuang, RY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :26815-26817
[4]   CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors [J].
Clegg, AO ;
Ashton, LJ ;
Biti, RA ;
Badhwar, P ;
Williamson, P ;
Kaldor, JM ;
Stewart, GJ .
AIDS, 2000, 14 (02) :103-108
[5]   Long-term non-progression in HIV infection: Definitions and epidemiological issues [J].
Easterbrook, PJ .
JOURNAL OF INFECTION, 1999, 38 (02) :71-73
[6]   Host factors and the pathogenesis of HIV-induced disease [J].
Fauci, AS .
NATURE, 1996, 384 (6609) :529-534
[7]   The estimated prevalence and incidence of HIV in 96 large US metropolitan areas [J].
Holmberg, SD .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :642-654
[8]   The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [J].
Huang, YX ;
Paxton, WA ;
Wolinsky, SM ;
Neumann, AU ;
Zhang, LQ ;
He, T ;
Kang, S ;
Ceradini, D ;
Jin, ZQ ;
Yazdanbakhsh, K ;
Kunstman, K ;
Erickson, D ;
Dragon, E ;
Landau, NR ;
Phair, J ;
Ho, DD ;
Koup, RA .
NATURE MEDICINE, 1996, 2 (11) :1240-1243
[9]   CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: Association with increased 2-year maternal mortality [J].
John, GC ;
Bird, T ;
Overbaugh, J ;
Nduati, R ;
Mbori-Ngacha, D ;
Rostron, T ;
Dong, T ;
Kostrikis, L ;
Richardson, B ;
Rowland-Jones, SL .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (01) :89-92
[10]   Polymorphism of CCR5 affecting HIV disease progression in the Japanese population [J].
Kageyama, S ;
Mimaya, JI ;
Yamada, K ;
Kurimura, T ;
Shiraki, K .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (11) :991-995